Kim Robert Young's Form 4 filing
4D Molecular Therapeutics, Inc. (FDMT) · filed Feb 7, 2024
- Accession no.
- 0000950170-24-012456
- Filed
- Feb 7, 2024
- Trade date
- Feb 5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $737.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kim Robert YoungCIK 0001971608 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | Common Stock | MOption exerciseAcquired | +12,000 | $18.66 | +$223,920 | 13,595 | Direct | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −12,000 | $30.05 | −$360,600 | 1,595 | Direct | |
| Feb 5, 2024 | Common Stock | MOption exerciseAcquired | +6,000 | $15.78 | +$94,680 | 7,595 | Direct | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −6,000 | $30.05 | −$180,300 | 1,595 | Direct | |
| Feb 5, 2024 | Common Stock | MOption exerciseAcquired | +6,000 | $8.04 | +$48,240 | 7,595 | Direct | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −6,000 | $30.05 | −$180,300 | 1,595 | Direct | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −552 | $30.05 | −$16,587.6 | 1,043 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | Common Stock | MOption exerciseDisposed | −120,000 | $0.00 | $0 | 138,000 | Direct | |
| Feb 5, 2024 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 64,000 | Direct | |
| Feb 5, 2024 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 54,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.